Julphar Saudi Arabia Oral Preparations
Annual capacities: 1 billion tablets, 300 million capsules, 30 million bottles of syrups and suspensions
Julphar has started building its pharmaceutical facility in Saudi Arabia in 2014. The plant will produce oral pharmaceutical formulations for the Saudi market. The facility will have a state-of-the-art oral solid dosage plant and oral liquid formulation plant. The oral solid dosage plant consists of an integrated granulation suite and two integrated blister packaging lines to produce oral solid products. The oral liquid plant has the manufacturing systems with two complete liquid filling and packaging lines to produce the oral liquid products complying with international cGMP standards – Saudi Arabia in particular. The fully automated plants have incorporated sophisticated processes and control systems, which consist of the raw material transfer through closed systems, recipe management with minimal operator intervention, automated cleaning to avoid the cross contamination, in-process controls systems to ensure the consistent product quality and higher standard clean utilities systems (PUW & Nitrogen) to produce the quality stable product. The Julphar Saudi Arabia plant has been built following the best international practices and the state-of-the-art production and packaging equipments are imported from Germany and Italy. The facility is expected to begin its operations in June 2017.